Document is current
Any future updates will be listed below
-
Authors
Nakano, Kiyotaka https://orcid.org/0000-0002-0285-2464
Oki, Eiji
Yamazaki, Masaki
Suzuki, Masami
Kawai, Shigeto
Zaitsu, Yoko
Nishime, Chiyoko
Ando, Koji
Nagae, Genta
Harimoto, Norifumi
Ota, Mitsuhiko
Kawazoe, Tetsuro
Nonaka, Kentaro
Natsugoe, Keita
Omori, Sachie
Saeki, Hiroshi
Aburatani, Hiroyuki
Yamazaki, Tatsumi
Maehara, Yoshihiko
-
Funding
Funding for this research was provided by:
Chugai Pharmaceutical
- License Information
-
More Information
Article History
Received: 22 October 2025
Accepted: 16 December 2025
First Online: 20 January 2026
Declarations
:
: K.N., M.Y., S.K. are employees of Chugai Pharmaceutical Co., Ltd. M.S. and C.N are employees of Central Institute for Experimental Medicine and Life Science. T.Y. is a board member of Central Institute for Experimental Medicine and Life Science. E.O. reports research funding from Guardant Health, and honoraria from Ono, Takeda, Eli Lilly and Bristol Myers Squibb.
: This study did not require ethical approval because it was a review of published articles and did not directly involve human or animal subjects.
